Results: A total of 575 patients received the survey, 341 (59.3%) returned it (mean age 47 years, 48% women). Only 10% were members of patients associations. Patients declared a median of 9 visits to primary care or specialty clinics in the last year, and 28% had visited an emergency room. In the last 3 years, 51% had been hospitalised. Only 44% reported to have regular follow-up from a nurse. Up to 73% search for information on diseases, therapies, lifestyle or diet in webpages, general or social media. Responses to the IEXPAC items (percentages that responded "mostly" + "always" to each item) are displayed in the Table. Mean score was 5.9 (SD 2.0), 28.8% of patients scored < 5. Items with the worst score were those related to access to or guidance for getting reliable health information or social resources, contact with other patients and follow-up after hospital discharge.
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Frequency of vaccination for herpes zoster (HZ) among inflammatory bowel disease (IBD) patients
. To prevent this complication it is recommended that everybody irrespective of IBD should get immunised. Although the age at which immunisation should be administered is variable among different societies, they all agree that by the age of 60 all patients, irrespective of IBD status should be immunised. Our aim was to evaluate the proportion of patients with IBD who are vaccinated for HZ. Methods: We used the Veterans Affairs (VA) database for our study as it is the largest integrated healthcare system in the USA and patients do not have to pay for vaccinations. The study period was from January 1, 2000, through June 30, 2016. Follow-up started at age 60 if they were already diagnosed with IBD or age at diagnosis of IBD if the onset of disease was after age 60. Follow-up ended if they got vaccinated, developed herpes, died, were lost to follow-up or end of the study period whichever was first. Baseline demographic characteristics at the time of start of follow-up were determined. Vaccination for HZ and development of herpes was identified by CPT and ICD 9 and 10 codes and were internally validated. Results: There were 40 496 patients in our cohort who met the inclusion criteria. 90.9 % were male. Over the follow-up period, a total of 7370 of patients were vaccinated. This translated into a vaccination rate of 18.2%. The follow-up period was 358 976.83 years for the entire cohort. While evaluating the age at which patients got vaccinated, instead of there being a large segment being vaccinated close to age 60 there was a steady annual increment. After the age of 70, 3436 (46.6%) patients got vaccinated (Images 1 and 2).
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Conclusions: Despite HZ vaccine being recommended and covered in the VA system for patients above age 60, only 18.2% of patients above this age were vaccinated and those who did get vaccinated got so at various time intervals after the age of 60. Greater efforts need to be made towards the further adoption of vaccination especially in view of the approval of a new potentially safer and more effective vaccine. of CD patients (6/97) had steroid dependency, and 2 CD children were refractory to steroid therapy. Biologicals were applied in 22% of children with CD during the 5 years (21/96). Three children with UC got biological therapy. Bowel resection was performed in 9% of CD children during the 5 years, no colectomy was performed in UC cases (0/37). Conclusions: Follow-up of paediatric IBD cases is difficult due to transition to adult health care. The management practice was different in Hungary from the international trends in 2010, however the disease course was similar to previous results.
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